| [1] |
LIU Zhaofeng, LI Ling, NA Shufang, YUE Jiang, YE Qifa.
Regulation mechanism of post-translational modification of farnesoid X receptor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1292-1298.
|
| [2] |
YANG Li, BAI Huhu, HE Shasha, JIN Yue, LIU Chengsong.
Tyrosine phosphorylation of TRPM3 ion channel mediates diabetes-induced heat hyperalgesia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 971-976.
|
| [3] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
| [4] |
CHEN Shengfu, LI Xiaolin, WANG Weigang, DU Weize, LI Maoxing.
Research progress on antipyretic effect of Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 334-344.
|
| [5] |
LIU Chen, FANG Mengdie, XU Hao, LI Chao, REN Juan, ZUO Bowen, ZHANG Yanmei.
Atractyloside targets the area of action of oncoprotein BORIS to inhibit cancer cell proliferation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1005-1013.
|
| [6] |
YANG Hechun, SHI Daohua .
Research progress of small molecule inhibitors that reverse tumor drug resistance by regulating tumor glucose metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 836-840.
|
| [7] |
ZHANG Chenhan, NIE Jingyun, XIN Pengfei, CHAI Chen, LI Bo.
Research progress of melatonin and pancreatic diseases#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1309-1314.
|
| [8] |
WANG Xiaoli, LU Shuping, DAI Jiale.
Role of MSX2 in melanoma cells for trametinib resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1147-1154.
|
| [9] |
LI Ling, ZHAO Huijia, CHEN Binyao, LIU Xiaohong, SUN Gongpeng, HAO Zhuowen, FAN Zhipeng, YUE Jiang, WU Jianguo, YE Qifa.
Relevance of CYP2R1 genetic polymorphism and individual therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1053-1059.
|
| [10] |
ZHAO Li, HUA Xia, TAN Ye, HU Chenglian.
Effects of sulforaphane-induced Akt/p70S6K signal transduction pathway on apoptosis of human nasopharyngeal cancer cells CNE-2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 786-791.
|
| [11] |
QUAN Haiyan, LIU Yuhuan, YANG Li, YANG Fang, QIN Xuping.
Improvement of CGRP on vascular endothelial cells insulin resistance via activation of cAMP/PPARγ/eNOS pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 615-622.
|
| [12] |
HAN Jinghong, LIU Yuchen, NIE Guohui.
Transcriptomic analysis of neonatal mammalian vestibular after hair cell injury by neomycin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 481-489.
|
| [13] |
YAN Jieping，ZHANG Shuijun，ZHANG Guobing，HU Ying，LUO Dan，JIANG Hongjuan，LI Minjing.
Protective effects of Butylphthalide on S-nitrosoglutathione-induced brain microvascular endothelial cells injury and potential mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 517-522.
|
| [14] |
DING Qiuhua, SHI Daohua.
Advances on the molecular mechanism of metformin's antitumor effect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 350-354.
|
| [15] |
ZHOU Jianhua, LIU Kelan, WU Ganbin.
Effects of anti-platelet individual treatment guided by CYP2C19 polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1364-1367.
|
